Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-human data presented on risperidone-ISM formulation

Oct. 11, 2011

GlycoVax discloses preclinical data on its proprietary glycoprotein vaccines

Oct. 11, 2011

Tetraphase Pharmaceuticals describes multiple novel tetracyclines

Oct. 11, 2011

BAY-1017858 shows promise in vitro and in vivo

Oct. 10, 2011

Scientists in Taiwan identify miRNA signature associated with incidence of oral cancer

Oct. 10, 2011

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Oct. 10, 2011

Promising phase III data disclosed on VX-770 in CF

Oct. 10, 2011

Study identifies SNPs associated with severity of A/H1N1/2009 influenza in children

Oct. 10, 2011

GSK FLAP inhibitor attenuates allergen-induced asthma responses in phase II trials

Oct. 10, 2011

TSRL discloses preclinical data on neuraminidase inhibitor prodrugs

Oct. 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...